Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
USD | Fiscal Year Ending | | Latest |
(in millions) | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | Dec-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 4,964 | 4,783 | 5,037 | 5,391 | 5,374 | 5,237 | 5,590 | 5,859 | 5,441 | 5,305 | | 5,305 |
% Growth | NA | -3.7% | 5.3% | 7.0% | -0.3% | -2.5% | 6.7% | 4.8% | -7.1% | -2.5% | | |
| | | | | | | | | | | | |
Cost of Revenue | (4,035) | (3,837) | (4,078) | (4,350) | (4,316) | (4,191) | (4,529) | (4,601) | (4,234) | (4,160) | | (4,160) |
Gross Profit | 929 | 946 | 959 | 1,041 | 1,058 | 1,046 | 1,062 | 1,258 | 1,208 | 1,145 | | 1,145 |
% Revenue | 18.7% | 19.8% | 19.0% | 19.3% | 19.7% | 20.0% | 19.0% | 21.5% | 22.2% | 21.6% | | 21.6% |
| | | | | | | | | | | | |
Research and Development | (22) | (23) | (21) | (23) | (23) | (22) | (24) | (23) | (24) | (23) | | (23) |
Selling and Marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
General and Admin | (505) | (488) | (518) | (527) | (523) | (532) | (1,085) | (556) | (621) | (601) | | (601) |
Other Inc / (Exp) | (9) | 68 | (43) | (43) | (64) | (160) | (44) | (108) | 62 | (302) | | (302) |
Total Operating Exp | (536) | (442) | (582) | (593) | (610) | (714) | (1,153) | (688) | (583) | (927) | | (927) |
| | | | | | | | | | | | |
Operating Income | 393 | 504 | 377 | 448 | 448 | 332 | (91) | 570 | 625 | 218 | | 218 |
% Revenue | 7.9% | 10.5% | 7.5% | 8.3% | 8.3% | 6.3% | -1.6% | 9.7% | 11.5% | 4.1% | | 4.1% |
| | | | | | | | | | | | |
Interest Expense | (55) | (52) | (53) | (58) | (62) | (72) | (59) | (96) | (125) | (145) | | (145) |
Pre-tax Income | 338 | 453 | 324 | 390 | 386 | 260 | (150) | 474 | 499 | 73 | | 73 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 88 | 96 | 96 | | 96 |
Provision for Taxes | (88) | (165) | (147) | (75) | (93) | (53) | 67 | (96) | (120) | (6) | | (6) |
Net Income to Company | 251 | 288 | 177 | 315 | 293 | 207 | (83) | 467 | 476 | 164 | | 164 |
% Margin | 5.0% | 6.0% | 3.5% | 5.8% | 5.4% | 4.0% | -1.5% | 8.0% | 8.7% | 3.1% | | 3.1% |
| | | | | | | | | | | | |
Minority Interest in Earnings | (0) | (1) | (2) | (1) | (1) | 0 | (3) | (0) | (1) | 0 | | 0 |
Net Income to Stockholders | 250 | 286 | 175 | 314 | 292 | 207 | (85) | 466 | 475 | 164 | | 164 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (88) | (96) | (96) | | (96) |
| | | | | | | | | | | | |
Net Income to Common | 250 | 286 | 175 | 314 | 292 | 207 | (85) | 378 | 379 | 68 | | 68 |
% Margin | 5.0% | 6.0% | 3.5% | 5.8% | 5.4% | 4.0% | -1.5% | 6.5% | 7.0% | 1.3% | | 1.3% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 2.46 | 2.83 | 1.75 | 3.12 | 2.90 | 2.06 | (0.86) | 3.86 | 3.85 | 0.69 | | 0.69 |
Diluted EPS (Continuing Ops) | 2.44 | 2.81 | 1.74 | 3.10 | 2.88 | 2.05 | (0.86) | 3.83 | 3.83 | 0.68 | | 0.68 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 101.48 | 101.09 | 100.24 | 100.54 | 100.74 | 100.94 | 99.61 | 97.99 | 98.29 | 98.64 | | 98.64 |
WA Diluted Shares Out. | 102.39 | 101.78 | 100.85 | 101.02 | 101.18 | 101.21 | 99.61 | 98.73 | 98.89 | 99.29 | | 99.29 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 338 | 453 | 324 | 390 | 386 | 260 | (150) | 474 | 499 | 73 | | 73 |
Addback: Net Interest Expense | 55 | 52 | 53 | 58 | 62 | 72 | 59 | 96 | 125 | 145 | | 145 |
Addback: Other Non Operating Expenses, Total | (10) | (11) | (9) | (11) | (5) | (5) | (11) | (14) | (21) | (1) | | (1) |
Addback: Depreciation & Amortization | 213 | 205 | 218 | 236 | 239 | 261 | 245 | 309 | 341 | 375 | | 375 |
Addback: Restructuring Charges | 39 | 40 | 38 | 40 | 45 | 68 | 9 | 42 | 48 | 65 | | 65 |
Addback: Merger / Acquisition Expenses | 2 | 5 | 14 | 14 | 9 | 5 | 18 | 70 | 33 | 225 | | 225 |
Addback: Goodwill Impairment | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (44) | (9) | | (9) |
Addback: Gain (Loss) On Sale Of Assets | 0 | (104) | 0 | 0 | 0 | 15 | 3 | 0 | (79) | 23 | | 23 |
Addback: Asset Writedown | 12 | 0 | 1 | 0 | 15 | 78 | 5 | 10 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | (33) | 0 | 0 | 0 | 0 | 0 | 20 | 0 | 0 | 0 | | 0 |
Adjusted EBITDA | 615 | 641 | 637 | 727 | 750 | 754 | 198 | 988 | 903 | 895 | | 895 |
% Margin | 12.4% | 13.4% | 12.6% | 13.5% | 14.0% | 14.4% | 3.5% | 16.9% | 16.6% | 16.9% | | 16.9% |
| | | | | | | | | | | | |
Adjusted EBIT | 402 | 436 | 420 | 491 | 511 | 492 | (47) | 679 | 562 | 521 | | 521 |
% Margin | 8.1% | 9.1% | 8.3% | 9.1% | 9.5% | 9.4% | -0.8% | 11.6% | 10.3% | 9.8% | | 9.8% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 251 | 288 | 177 | 315 | 293 | 207 | (83) | 467 | 476 | 164 | | 164 |
Addback: Unusual Items | 20 | (57) | 52 | 55 | 69 | 165 | 55 | 123 | (42) | 304 | | 304 |
Less: Tax Benefit of Unusual Items (26%) | (5) | 15 | (14) | (14) | (18) | (43) | (14) | (32) | 11 | (79) | | (79) |
Adjusted Net Income | 265 | 246 | 216 | 355 | 344 | 329 | (42) | 557 | 445 | 389 | | 389 |
% Margin | 5.3% | 5.1% | 4.3% | 6.6% | 6.4% | 6.3% | -0.8% | 9.5% | 8.2% | 7.3% | | 7.3% |